Eko Health, Inc.

Eko Health, Inc. specializes in digital auscultation solutions, primarily producing digital stethoscope components like chestpieces and earpieces. Their portfolio also includes software tools, such as the Eko Foundation Analysis Software with Transformers (EFAST) and the Eko Low Ejection Fraction Tool (ELEFT), which are designed to analyze cardiac function. Additionally, they offer attachments like the CORE Digital Attachment to enhance digital stethoscope systems.

Eko Health, Inc. is based in the United States. Since the company operates in the US, its devices must comply with FDA regulations. The FDA classifies their products as Class II or Class IIa, which means they undergo specific regulatory pathways, such as 510(k) clearance, to demonstrate safety and effectiveness before entering the market. This classification ensures that the devices meet stringent standards for performance and risk.

Eko Health, Inc.’s devices are listed in multiple regulatory databases to ensure transparency and traceability. Their products appear in the FDA’s 510(k) database, which tracks cleared medical devices in the United States. Additionally, some of their entries are included in the EU’s eudamed database, which serves as a central registry for medical devices authorized under EU regulations. These listings help healthcare providers and regulators verify compliance and device details.

Eko Health, Inc.’s devices are classified under FDA regulations as either Class II or Class IIa. Class II devices generally pose moderate risk and require special controls to ensure their safety and effectiveness, such as performance standards or post-market surveillance. Class IIa devices are a subset of Class II with slightly lower risk but still require regulatory oversight. These classifications determine the regulatory pathway—such as 510(k) clearance in the US or equivalent EU processes—that must be followed before a device can be marketed.

Software tools like the Eko Foundation Analysis Software with Transformers (EFAST) and the Eko Low Ejection Fraction Tool (ELEFT) are integral to Eko Health’s diagnostic ecosystem. These tools are designed to analyze cardiac auscultation data collected via their digital stethoscopes, providing clinicians with automated insights into heart function, such as ejection fraction assessments. By integrating software with hardware, Eko Health enhances diagnostic accuracy and efficiency, supporting evidence-based decision-making in clinical settings.